Title:
COMPOSITION AND METHOD FOR REDUCING POST-PRANDIAL BLOOD GLUCOSE
Document Type and Number:
WIPO Patent Application WO2003092603
Kind Code:
A3
Abstract:
A nutritional intervention composition for reducing post-prandial blood glucose levels in humans, including between about 0.1 mg and about 500 mg of a proteinase inhibitor that is administered prior to the meal. The composition is effective for treating or ameliorating the effects of hyperglycemia and Type II diabetes. The composition also is effective in combating obesity. The proteinase inhibitor is preferably isolated from plant material, such as potatoes, soy, and beans. Potato proteinase inhibitor II and soybean Bowman-Birk inhibitor are included in the group of effective proteinase inhibitors.
Inventors:
AUSICH RODNEY
DEFREITAS ZORAIDA
SHEABAR FAYAD
SHAO ANDREW
NEWMAN JERRY
DEFREITAS ZORAIDA
SHEABAR FAYAD
SHAO ANDREW
NEWMAN JERRY
Application Number:
PCT/US2003/013536
Publication Date:
February 19, 2004
Filing Date:
April 30, 2003
Export Citation:
Assignee:
KEMIN CONSUMER CARE L C (US)
International Classes:
A61K45/00; A23L1/30; A61K38/55; A61K38/56; A61P3/08; (IPC1-7): A61K35/78; A01N37/18
Foreign References:
| US5545672A | 1996-08-13 | |||
| US5468727A | 1995-11-21 | |||
| US4793996A | 1988-12-27 |
Other References:
See also references of EP 1509239A4
Download PDF:
Previous Patent: NOVEL TISSUE FACTOR TARGETED THROMBOMODULIN FUSION PROTEINS AS ANTICOAGULANTS
Next Patent: VASCULARIZATION ENHANCED GRAFT CONSTRUCTS
Next Patent: VASCULARIZATION ENHANCED GRAFT CONSTRUCTS